Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

16.78

-0.75 (-4.28%)

At close: May 30, 2025, 4:00 PM

16.79

+0.01 (0.06%)

After-hours: May 30, 2025, 7:54 PM EDT

Teva Pharmaceutical Market Cap

Teva Pharmaceutical has a market cap or net worth of $19.25 billion as of May 30, 2025. Its market cap has increased by 0.66% in one year.

Market Cap

19.25B

Enterprise Value

34.49B

1-Year Change

0.66%

Ranking

#566

Market Cap Chart

Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $19.25B, an increase of 215.41%. That is a compound annual growth rate of 4.43%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	20.11B	-19.49%
Dec 31, 2024	24.97B	113.39%
Dec 29, 2023	11.70B	15.54%
Dec 30, 2022	10.13B	14.65%
Dec 31, 2021	8.84B	-16.46%
Dec 31, 2020	10.58B	-1.18%
Dec 31, 2019	10.70B	-31.87%
Dec 31, 2018	15.71B	-18.33%
Dec 29, 2017	19.23B	-41.54%
Dec 30, 2016	32.90B	-41.16%
Dec 31, 2015	55.92B	2.69%
Dec 31, 2014	54.45B	43.98%
Dec 31, 2013	37.82B	7.52%
Dec 31, 2012	35.17B	-7.04%
Dec 30, 2011	37.84B	-21.40%
Dec 31, 2010	48.14B	-3.59%
Dec 31, 2009	49.93B	45.08%
Dec 31, 2008	34.41B	-6.66%
Dec 31, 2007	36.87B	83.46%
Dec 29, 2006	20.10B	-25.46%
Dec 30, 2005	26.96B	62.59%
Dec 31, 2004	16.58B	13.05%
Dec 31, 2003	14.67B	46.88%
Dec 31, 2002	9.99B	-51.34%
Dec 29, 2000	20.52B	104.36%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	645.71B
Johnson & Johnson	367.14B
AbbVie	325.80B
Novo Nordisk	305.07B
UnitedHealth Group	271.23B
Abbott Laboratories	231.09B
Novartis AG	221.98B
AstraZeneca	219.74B

Market Cap Rankings